Notice to Shareholders

22nd Nov 2024 16:26

RNS Number : 3949N
Invesco Markets II PLC
22 November 2024
 

 

 

Invesco Markets plc

Ground Floor, 2 Cumberland Place, Fenian Street, Dublin 2, Ireland

Telephone +353 1 439 8000 www.invesco.com

 

 

 

 

 

IMPORTANT: This letter is important and requires your immediate attention. If you have any questions about the content of this letter, you should seek independent professional financial advice.

 

22 November 2024

Invesco Markets II plc (the "Company")

 

Funds

ISINs

NAV Rates

NAV Date

Invesco Commodity Composite UCITS ETF

IE00B4TXPP71

96.4979 USD

20 November 2024

(the "Fund")

Dear Shareholder

Further to the shareholder notice dated 4 October 2024, the Company confirms that the shares of the Funds were redeemed on 20 November 2024 and the resulting cash proceeds will be paid on or around 27 November at the rates set out in the above table.

The Company has requested the cancellation of the listings of the Funds. This was effective as of close of business on 18 November 2024.

Shareholders should consult their own professional adviser as to the specific tax implications of the termination under the laws of the countries of their nationality, residence, domicile or incorporation.

If you have any queries arising from this notice, please call Invesco on +353 1 439 8000 or contact us at [email protected].

 

 

Yours sincerely,

 

Name: Lisa Martensson Title: Director

Date: 22.11.24

For and on behalf of Invesco Markets plc

 

 

 

Directors: Gary Buxton (British/Irish), Feargal Dempsey, Sarah Deidre Gormley, (Katy Walton) Jones (British), Lisa Martensson (Swedish)

Invesco Markets plc, registered in Ireland as an open-ended variable capital umbrella investment company with limited liability and segregated liability between sub-funds.

Registration number: 463397. Registered office: Ground Floor, 2 Cumberland Place, Fenian Street, Dublin 2, Ireland

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBTBFTMTTTBII